Information Provided By:
Fly News Breaks for August 5, 2016
ACAD
Aug 5, 2016 | 10:57 EDT
Aegis analyst Robert Leboyer downgraded ACADIA Pharmaceuticals to Hold with a $41 price target saying the stock at current levels is fairly valued.
News For ACAD From the Last 2 Days
There are no results for your query ACAD